Paul Elson

18.3k total citations · 3 hit papers
334 papers, 13.4k citations indexed

About

Paul Elson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Paul Elson has authored 334 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Pulmonary and Respiratory Medicine, 128 papers in Oncology and 78 papers in Molecular Biology. Recurrent topics in Paul Elson's work include Renal cell carcinoma treatment (98 papers), Cancer Genomics and Diagnostics (53 papers) and Renal and related cancers (40 papers). Paul Elson is often cited by papers focused on Renal cell carcinoma treatment (98 papers), Cancer Genomics and Diagnostics (53 papers) and Renal and related cancers (40 papers). Paul Elson collaborates with scholars based in United States, India and United Kingdom. Paul Elson's co-authors include Ronald M. Bukowski, Brian I. Rini, Laura S. Wood, Robert Dreicer, Tarek Mekhail, Patrick J. Loehrer, Jorge A. García, Ali Golshayan, Bartholomäus Böhm and Victor W. Fazio and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Paul Elson

325 papers receiving 13.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

1992 752 citations Paul Elson et al. Journal of Clinical Oncology profile →
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

2009 690 citations Jennifer S. Ko, Arnold H. Zea et al. Clinical Cancer Research profile →
A Prospective, Randomized Trial Comparing Laparoscopic Versus Conventional Techniques in Colorectal Cancer Surgery: A Preliminary Report

1998 525 citations Paul Elson et al. profile →

Peers

Countries citing papers authored by Paul Elson

Since Specialization

Citations

This map shows the geographic impact of Paul Elson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Elson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Elson more than expected).

Fields of papers citing papers by Paul Elson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Elson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Elson. The network helps show where Paul Elson may publish in the future.

Co-authorship network of co-authors of Paul Elson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Elson. A scholar is included among the top collaborators of Paul Elson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Elson. Paul Elson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A quantitative and comparative evaluation of stereotactic spine radiosurgery local control: proposing a consistent measurement methodology 2022 ·Neurosurgical FOCUS ·Ran Harel, (unknown), Todd Emch, Paul Elson, Samuel T. Chao, John H. Suh, Lilyana Angelov	0
2	Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience 2017 ·Blood ·Shafia Rahman, Dana E. Angelini, Paul Elson, (unknown), (unknown), Meghan O’Brien, (unknown), Jung Min Song, Keith R. McCrae, Alok A. Khorana	3
3	Predictors for Recurrent 30-Day Unplanned Readmissions in Patients with Hematologic Malignancies 2017 ·Blood ·(unknown), Hina Ahmed, Sagar S. Patel, Bhumika Patel, Paul Elson, (unknown), Aaron T. Gerds, Hetty E. Carraway, Anjali S. Advani, Aziz Nazha, Alberto J. Montero, Brad Pohlman, (unknown), (unknown), (unknown), Katherine Tullio, Kimberly Bell, Matt Kalaycio, Mikkael A. Sekeres, Sudipto Mukherjee	1
4	Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase–Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase 2016 ·American Journal Of Pathology ·Divya Sahu, Sounak Gupta, Andrew M. Hau, Kazufumi Nakashima, (unknown), Stephen Searles, Paul Elson, John S. Bomalaski, Darren E. Casteel, Gerry R. Boss, Donna E. Hansel	25
5	The Degree and Effect Of Weight Loss In Acute Myeloid Leukemia Patients Receiving Induction and Post-Remission Chemotherapy 2013 ·Blood ·Surbhi Sidana, Sudipto Mukherjee, Paul Elson, David J. Seastone, Aziz Nazha, (unknown), (unknown), (unknown), (unknown), (unknown), Anjali S. Advani, Matt Kalaycio, Mikkael A. Sekeres	3
6	Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis 2012 ·PLoS ONE ·Fabı́ola Traina, Valeria Visconte, A. Jankowska, Hideki Makishima, Christine L. O’Keefe, Paul Elson, Yingchun Han, Fred H. Hsieh, Mikkael A. Sekeres, Raghuveer Singh Mali, Matt Kalaycio, Alan Lichtin, Anjali S. Advani, Hien K. Duong, Edward A. Copelan, Reuben Kapur, Sara Teresinha Olalla Saad, Jaroslaw P. Maciejewski, Ramón V. Tiu	86
7	Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group 2011 ·Clinical Cancer Research ·Judith Manola, Patrick Royston, Paul Elson, (unknown), Madhu Mazumdar, Sylvie Négrier, Bernard Escudier, Tim Eisen, Janice P. Dutcher, Michael B. Atkins, Daniel Yick Chin Heng, Toni K. Choueiri, Robert J. Motzer, Ronald M. Bukowski	148
8	Follicular programmed death 1–positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma 2011 ·Human Pathology ·(unknown), Brad Pohlman, Paul Elson, Eric D. Hsi	91
9	Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature 2011 ·Modern Pathology ·Mary K. Samplaski, Warren D.W. Heston, Paul Elson, Cristina Magi‐Galluzzi, Donna E. Hansel	50
10	HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization 2011 ·Modern Pathology ·Christina B. Ching, Mohammed A. Amin, Raymond R. Tubbs, Paul Elson, (unknown), Robert Dreicer, Amr Fergany, Donna E. Hansel	83
11	Gene Regulatory and Clinical Effects of Interferon β in Patients with Metastatic Melanoma: A Phase II Trial 2011 ·Journal of Interferon & Cytokine Research ·Ernest C. Borden, Barbara Jacobs, (unknown), Lisa Rybicki, Paul Elson, Thomas Olencki, Pierre L. Triozzi	25
12	Efficacy of Rabbit Anti-Thymocyte Globulin (ATG) Compared to Horse ATG In Severe Aplastic Anemia 2010 ·Blood ·(unknown), Mohammed Shaik, Yuka Sugimoto, Michael J. Clemente, Ramón V. Tiu, Sanjay Mohan, Nelli Bejanyan, Paul Elson, Matt Kalaycio, Anjali S. Advani, Ronald Sobecks, Alan Lichtin, Mikkael A. Sekeres, Jaroslaw P. Maciejewski	2
13	Sunitinib rechallenge in metastatic renal cell carcinoma patients 2010 ·Cancer ·Ivan Zama, Thomas E. Hutson, Paul Elson, James M. Cleary, Toni K. Choueiri, Daniel Y.C. Heng, Nikhil H. Ramaiya, M. Dror Michaelson, Jorge A. García, Jennifer J. Knox, Bernard Escudier, Brian I. Rini	108
14	Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients breakdown → 2009 ·Clinical Cancer Research ·Jennifer S. Ko, Arnold H. Zea, Brian I. Rini, Joanna Ireland, Paul Elson, Peter A. Cohen, Ali Golshayan, Patricia Rayman, Laura S. Wood, Jorge A. García, Robert Dreicer, Ronald M. Bukowski, James H. Finke	690
15	Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients 2008 ·Blood ·Mikkael A. Sekeres, Paul Elson, Matt Kalaycio, Anjali S. Advani, Edward A. Copelan, Stefan Faderl, Hagop M. Kantarjian, Elihu H. Estey	146
16	Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma 2007 ·Journal of Clinical Oncology ·Toni K. Choueiri, A. Plantade, Paul Elson, Sylvie Négrier, Alain Ravaud, Stéphane Oudard, Ming Zhou, Brian I. Rini, Ronald M. Bukowski, Bernard Escudier	311
17	Use of Melphalan, Thalidomide, and Dexamethasone in Treatment of Refractory and Relapsed Multiple Myeloma 2002 ·Medical Oncology ·Gordan Srkalović, Paul Elson, (unknown), Mary Ann Karam, Mohamad A. Hussein	38
18	Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis. 2001 ·PubMed ·S. A. Vaziri, Lisa M. Krumroy, Paul Elson, G. T. Budd, Gerarda Darlington, Jonathan P. Myles, Raymond R. Tubbs, Graham Casey	51
19	Shanxi Province Cervical Cancer Screening Study: A Cross-Sectional Comparative Trial of Multiple Techniques to Detect Cervical Neoplasia 2001 ·Gynecologic Oncology ·Jerome L. Belinson, You‐Lin Qiao, Robert G. Pretorius, Wenya Zhang, Paul Elson, (unknown), Qin Pan, C. Fischer, Attila T. Lörincz, David J. Zahniser	275
20	High-dose lymphoblastoid interferon in advanced renal cell carcinoma: an Eastern Cooperative Oncology Group Study. 1987 ·PubMed ·D L Trump, Paul Elson, Ernest C. Borden, James Harris, Richard L. Tuttle, John K. Whisnant, M. M. Oken, (unknown), John C. Ruckdeschel, T. E. Davis	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact